Shanghai Fosun Pharmaceutical (Group) Co(DE:08HH)
€1.95+0.05 (+0.77%)
DE:08HH
Shanghai Fosun Pharmaceutical (Group) Co Revenue
€1.95
At close:+0.05 (+0.77%)
Shanghai Fosun Pharmaceutical (Group) Co (08HH) Revenue
0 Followers
Shanghai Fosun Pharmaceutical (Group) Co Revenue
Shanghai Fosun Pharmaceutical (Group) Co had a revenue of 10.02B in the quarter ending Sep 30, 2026, with -50.13%. This bring the company's revenue in the last twelve months to 61.89B, Increased 0.23%. In the fiscal year ending Dec 31, 2025, Shanghai Fosun Pharmaceutical (Group) Co had annual revenue of 40.42B with -1.57% growth.
- Revenue (ttm)
- 61.89B
- Revenue Growth
- 2.13%
- P/S Ratio
- 0.19
- Revenue/Employee
- EUR 995,599
- Employees
- 40,603
- Market Cap
- EUR 7.73B
Revenue Chart
Shanghai Fosun Pharmaceutical (Group) Co Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 40.42B | -642.89M | -1.57% |
| Dec 31, 2024 | 41.07B | -332.34M | -0.80% |
| Dec 31, 2023 | 41.40B | -2.55B | -5.81% |
| Dec 31, 2022 | 43.95B | 4.95B | 12.68% |
| Dec 31, 2021 | 39.01B | 8.70B | 28.70% |
| Dec 31, 2020 | 30.31B | 1.72B | 6.02% |
| Dec 31, 2019 | 28.59B | 3.67B | 14.72% |
| Dec 31, 2018 | 24.92B | 6.38B | 34.45% |
| Dec 31, 2017 | 18.53B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.